SPRY 8-K 2026-07-17

ARS Pharmaceuticals, Inc. (SPRY) 8-K dated 2026-07-17 — accession 0001193125-26-307773. This URL is the filing, not the SPRY hub.

ARS Pharmaceuticals, Inc. (SPRY) is a biotechnology company listed on NASDAQ.

ARS Pharmaceuticals, Inc. filed a 8-K on 2026-07-17. Accession 0001193125-26-307773.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported SPRY revenue for 2026-06-30 was $56.3M. Net income was -$123.0M. SPRY currently screens at market cap $983.1M.

Not investment advice. The SPRY SEC hub lists recent forms. The stock page is the research view.